Search Results - "Bocanegra Martín, C."

CP-157 Risk factors associated with thromboembolic disease in hospitalised patients: an assessment in a general specialties hospital by Torres, MI Sierra, Soto, CM Valencia, del Moral, R Sánchez, Guzmán, MD Toscano, Gómez, E Sánchez, Martín, C Bocanegra

“…BackgroundThromboembolic disease (TED) is a complex condition in which the interaction between genetic, acquired and environmental factors determines the onset…”
Get full text

PS-025 Analysis of the utilisation of zolpidem in hospitalised patients by Rey, MB Contreras, Gómez, E Sánchez, Feria, D Yáñez, Galán, M Alcalá, Molins, E Rodríguez, Martín, C Bocanegra

“…BackgroundZolpidem is used for the short term treatment of insomnia. Recently, new recommendations about its normal recommended daily dose have been published:…”
Get full text

5PSQ-046 Direct-acting antivirals for hepatitis c virus in hiv co-infected patients by Rey, MB Contreras, Gutiérrez, J Estaire, Moral, R Sánchez del, Alonso, MM Romero, Raya, MA Bolivar, Martín, C Bocanegra

“…BackgroundThe development of new direct acting antivirals (DAAs) for hepatitis C virus (HCV) represents an evolution in the treatment. As HIV-HCV coinfection…”
Get full text

3PC-024 Application of a matrix risk to an appropriate compounding process of aflibercept and ranibizumab intravitreal injections by Madroñal, IM Carrión, Gómez, E Sánchez, Rey, MB Contreras, Milá, JI Ynfante, Martín, C Bocanegra, Molíns, E Rodríguez

“…BackgroundCompounded sterile drugs have to be prepared in appropriate conditions that ensure their safety in order to prevent medication error and avoid…”
Get full text

5PSQ-042 Acute eosinophilic pneumonia secondary to daptomycin: a case report by Feria, D Yáñez, Rey, MB Contreras, Gomez, E Sanchez, Saiz, S Grutzmancher, Martin, C Bocanegra

“…BackgroundA 81-years-old female was admitted due to a surgical cleaning of an infected knee prosthesis and the administration of targeted antibiotics. After…”
Get full text

4CPS-125 Use of eribulin in locally advanced or metastatic breast cancer by Rey, MB Contreras, Martínez, MT Garrido, Madroñal, IM Carrión, Feria, D Yáñez, Gómez, E Sánchez, Martin, C Bocanegra

“…BackgroundEribulin has been approved for locally advanced or metastatic breast cancer after at least one previous chemotherapy regimen for advanced disease,…”
Get full text

PS-008 Degree of compliance with the standards of high alert medications established by the institute for safe medication practices in a secondary hospital by Madroñal, IM Carrion, Gomez, E Sanchez, del Moral, R Sanchez, Mancha, MT Lopez, Torres, MI Sierra, Martin, C Bocanegra

“…BackgroundHigh alert medications are drugs that bear a heightened risk of causing significant patient harm when used in error. The Institute for Safe…”
Get full text

464 INFECTIVITY RATIO COULD EXPLAIN WHY SUBJECTS WITH FAVORABLE ILE-28B GENOTYPE HAD LOWER RATES OF SUSTAINED VIROLOGICAL RESPONSE by Macías, F.M. Jiménez, Casado Monge, P.G, Alor, F. Barrero, Ramos Lora, M, de la Llave, E. Pujol, Ruíz-Frutos, C, Rodríguez, J.L. Robles, Almeda, L. Galisteo, Conde-García, J, Salinas-Martín, M.V, Martín, C. Bocanegra, Saiz, S. Grutzmancher, Mazuelos, C. Contreras, Muñoz, D. Merino

Get full text

Simplificación del tratamiento antirretroviral: una buena alternativa para nuestros pacientes y para la sostenibilidad de nuestro sistema sanitario by González Rivas, L., Sánchez Gómez, E., Sánchez del Moral, R., Grutzmancher Saiz, S., Pujol de la Llave, E., Bocanegra Martín, C.

“…Describir la efectividad, seguridad, adherencia y ahorro económico de la monoterapia basada en lopinavir/ritonavir. Estudio observacional, descriptivo y…”
Get full text

Cost-effectiveness analysis of tenofovir versus zidovudine in combination therapy with efavirenz and lamivudine for the treatment of HIV in naive patients by Fernández Lisón, L C, Pujol de la Llave, E, Hevia Alonso, A, Garrido Martínez, M T, Bocanegra Martín, C

“…To assess tenofovir + lamivudine + efavirenz versus zidovudine + lamivudine + efavirenz in treatment-naive patients using a cost-effectiveness analysis. A…”
Get full text

Análisis coste-eficacia de tenofovir versus zidovudina en terapia combinada con efavirenz y lamivudina para el tratamiento de VIH en pacientes no pretratados by Fernández Lisón, L.C., Pujol de la Llave, E., Hevia Alonso, A., Garrido Martínez, M.T., Bocanegra Martín, C.

“…Evaluar los regímenes en pacientes no pretratados de tenofovir + lamivudina + efavirenz versus zidovudina + lamivudina + efavirenz mediante un estudio…”
Get full text

Simplification of antiretroviral therapy: a good choice for our patients and the sustainability of our health care system by González Rivas, L, Sánchez Gómez, E, Sánchez del Moral, R, Grutzmancher Saiz, S, Pujol de la Llave, E, Bocanegra Martín, C

“…To describe the efficacy, safety, compliance and cost savings of lopinavir/ritonavir monotherapy. Observational, descriptive and retrospective study evaluating…”
Get more information